Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06317298
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2023-12-05
Brief Title:
Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
Sponsor:
Organization:
Peking University First Hospital